Snap Inc. Stock Outperforms Competitors On Strong Trading Day

Cyclo Therapeutics Equity Warrants Exp 14th Nov 2025 *W EXP 12/11/2025

Change company Symbol lookup

Select an option...

CYTHW Cyclo Therapeutics Equity Warrants Exp 14th Nov 2025 *W EXP 12/11/2025

FR First Industrial Realty Trust Inc

PNI PIMCO New York Municipal Income Fund II

NIB iPath? Bloomberg Cocoa Subindex Total Return(SM) ETN

DG Dollar General Corp

SPCO Stephan Co

KEX Kirby Corp

GM General Motors Co

F Ford Motor Co

MSFT Microsoft Corp

Health Care : Biotechnology | Small Cap Value

Company profile

Cyclo Therapeutics, Inc. is a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease. The Company's lead drug candidate, Trappsol Cyclo (hydroxypropyl beta cyclodextrin) is for the treatment of Niemann-Pick Type C disease (NPC). NPC is a rare and fatal cholesterol metabolism disease that impacts the brain, lungs, liver, spleen, and other organs. It is also focusing on the use of cyclodextrins in the treatment of Alzheimer's disease. The Company's product lines include Trappsol and Aquaplex. It sells its chemical products directly to customers in the pharmaceutical, diagnostics, and industrial chemical industries, and to chemical supply distributors. The Company also sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs.

Snap Inc. Stock Outperforms Competitors On Strong Trading Day

5:20 pm ET June 15, 2022 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Snap Inc. (SNAP) surged 10.83% to $13.20 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 2.50% to 11,099.15 and the Dow Jones Industrial Average rising 1.00% to 30,668.53. The stock's rise snapped a five-day losing streak. Snap Inc. closed $70.14 below its 52-week high ($83.34), which the company achieved on September 24th.

The stock outperformed some of its competitors Wednesday, as Apple Inc. (AAPL) rose 2.01% to $135.43 and Twitter Inc. (TWTR) rose 2.07% to $37.99. Trading volume (59.1 M) eclipsed its 50-day average volume of 45.9 M.

Data source: Dow Jones Market Data, FactSet. Data compiled June 15, 2022.

(END) Dow Jones Newswires

June 15, 2022 17:20 ET (21:20 GMT)